7.7.1. introduction. treatment metastatic uc remained largely unchanged since pivotal trials published 20 years ago set standard care first-line treatment cisplatin-based combinations demonstrating os benefit. longstanding paradigm challenged past years introduction immunotherapy using checkpoint inhibitors finally upended october 2023 presentation results two practice-changing randomised clinical trials (rcts) demonstrating overall survival benefit first line setting platinum-based chemotherapy (ev-302/keynote a39 checkmate 901) . updated guidelines reflect results two trials impact first later lines management patients metastatic bladder cancer.